June 2022 | Volume 05 Journal of Immune Disorders & Therapy

Annual Congress on

COVID & COVID MUTATIONS June 09, 2022| Webinar

Hosting Organization: Pulsus 35 Ruddlesway, Windsor, Berkshire, SL4 5SF Ph: +44 7418 603 803 [email protected]

Scientific Program COVID Mutations 2022 Page 2

Webinar

Scientific Program

2022

Opening Ceremony/ 09:00-09:30 Thursday, June 09, 2022 Keynote Forum 09:30-10:10 Title: Healthcare workers’ knowledge and perception of the SARS-CoV-2 Omicron variant: A multinational cross-sectional study Mohammadjavad Ashrafi Mahabadi | Iran University of Medical Sciences, Iran 10:10-10:50 Title: Role of plant and algal metabolites in the fight against COVID-19 pandemic Indrajeet Kumar | Hindu University | India Refreshment Break 10:50-11:00 Sessions on: COVID | Virus in Body | Post COVID consequences | Symptomology of COVID 11:00-11:30

Title: Evaluating knowledge level of rational drug use in patients with COVID-19 Sengal Bagci | Taylan Hakkari University | Turkey

Title: Targeting the conserved sequence of the substrate for the proteinase of SARS11:30-12:00 CoV-19 using nano-networks: Efficacy, stability and no cytotoxicity Alaa F Nahhas | King Abdulaziz University | KSA Title: About COVID- 19 in Africa: Understanding the environment pollution by 12:00-12:30 the pandemic in Chad during the mutations Appolinaire Rititingar | Campus Numrique Francophone | Chad 12:30-13:00

Title: The challenges Of Covid-19 and the Novel vaccines Jane Lucie Kimani | Madre Giuseppina Vannini Hospital | Italy Lunch Break 13:00-13:30

Sessions on: COVID and Pulmonary Effects | Herbs for COVID | Nursing Role in Covid Title: Transcriptome and SARS-CoV-2 biological network directed analysis to 13:30-14:00 overcome various mutational and treatment limitations Om Prakash Sharma | Innoplexus AG | Germany 14:00-14:30

Title: Symptomatologie DU COVID-19 Isaac Papy Katembo Luete | MATETE general reference hospital | Kinshasa

Title: Defective M2 Macrophage Activation And TLR-4 UP-Regulation is responsible for COVID-19 lung disease with the crucial involvement of medullary and 14:30-15:00 resident megacaryocytes UP-Regulation, An authoptic based study of lethal SARSCoV-2 Giuseppe Pannone | University of Foggia | Italy

Young Research Forum 15:00-15:20

Title: Alternative mechanisms of apoptosis in lethal COVID-19 disease Giuseppe Pannone | University of Foggia | Italy

Thanks Giving and Closing Ceremony

COVID Mutations 2022 Page 4

PUBLISHER OF MEDICAL PEER REVIEW JOURNALS SINCE 1984

35Years

of Excellence in Medical Publishing

Pulsus is a publisher of scientific, technical, clinical and medical journals. Founded in 1984, Pulsus Group has remained faithful to its commitment to publish world-class, peer-review medical journals, highly respected by physicians and researchers. Endorsed by medical societies, Pulsus is an ardent supporter of international medical research and publishes journals in association with International medical and scientific societies.

Peer Reviewed Journals

Endorsed by Society

Interventional Cardiology

• American Research & Policy Institute • Autism Community Network • Brazil Federal District Otorhinolaryngologist Society

Clinical Practice (Therapy)

• Canadian Association of Neurophysiological Monitoring (CANM)

International Journal of Anatomical Variations

• Canadian Society for Aesthetic Plastic Surgery

Current Research: Cardiology

Current Research: Integrative Medicine

Diabetes Management International Journal of Clinical Skills International Journal of Clinical Rheumatology Pharmaceutical Bioprocessing

• Canadian Society for Surgery of the Hand • Canadian Society of Plastic Surgeons • European Biotechnology Thematic Network Association • Groupe pour l’Avancement de la Microchirurgie Canada • International Society for Ceramics in Medicine

Imaging in Medicine

• International Society of Addiction Medicine

Clinical Investigation

• IVF World Wide

Canadian Hearing Report

• National Biosafety Association • Neurootological and Equilibriometric Society

Canadian Ionm News

• Sonography Canada

Journal Phlebology and Lymphology

• Thalassaemia International Federation

Journal of Sexual & Reproductive Medicine

• World Association of Integrated Medicine • World Association of Medical Sciences • World Federation of Pediatrics Intensive and Critical Care Societies

Submit manuscripts through the journal's online submission and tracking system which is located at respective journal home page: https://www.pulsus.com/ 35 Ruddlesway, Windsor, Berkshire, SL4 5SF, Ph: +44-203-769-1778, +44-182-827-0013 Fax: +44-203-004-1157, E-mail: [email protected]

Annual Congress on COVID & COVID Mutations June 09, 2022 | Webinar

Supporting Journals

Page 6

Supporting Journals Journal of Immune Disorders & Therapy Journal of Clinical Microbiology and Infectious diseases Journal of Clinical Diagnosis and Treatment Journal of Chest and Lung Research Journal of Current Research Cardiotogy

COVID Mutations 2022 Page 7

Annual Congress on COVID & COVID Mutations June 09, 2022 | Webinar

Keynote Forum

Page 8

Mohammadjavad Ashrafi Mahabadi, J Immune Disord Ther,

Annual Congress on

Volume 05

COVID & COVID Mutations June 09, 2022 | Webinar

Mohammadjavad Ashrafi Mahabadi Iran University of Medical Sciences, Iran Received date: 02-04-2022 | Accepted date: 04-04-2022 | Published date: 30-06-2022

Healthcare workers’ knowledge and perception of the SARS-CoV-2 Omicron variant: A multinational cross-sectional study

I

n late November 2021, a new SARS-CoV-2 Variant of Concern (VOC) named Omicron (initially named B.1.1.529) was first detected in South Africa. The rapid spread of the SARS-CoV-2 Omicron variant became globally dominantand the currently available COVID-19 vaccines showed less protection against this variant. This study aimed to investigate healthcare workers’ (HCWs) knowledge and perceptions about the novel SARS-CoV-2 Omicron variant. A cross-sectional anonymous electronic survey concerning the SARS-CoV-2 Omicron variant was conducted among HCWs during the second week of January 2022. The survey instrument was distributed through social media among HCWs to explore awareness (2 items), knowledge (10 items), source of information (1 item) and perceptions (10 items). Respondents who answered ≥80% of the items correctly were considered as having good knowledge and perception. A total of 940 of the 1054 HCW participants completed the survey (response rate: 89.1%); they had a mean age of 31.2 ± 11.2 years, most were doctors (45.7%)and most were from Asia (64.3%). All the participants were aware of the SARS-CoV-2 Omicron variant (100%). Only 36.3% attended lectures/discussions about Omicron and used news media to obtain information. Only a quarter of the HCWs demonstrated good knowledge (24.3%, n = 228) and perception (20.6%) about Omicron. However, while significant differences were observed in the knowledge and perception among HCWs, only a small proportion of doctors exhibited good knowledge (13%) and perception (10%) about the Omicron variant. HCWs who had participated in training/discussion related to the Omicron variant were more likely to have higher knowledge and perception scores (odds ratio: 1.80; 95% confidence interval: 1.04–3.11). As the SARS-CoV-2 Omicron variant spreads rapidly across the globe, ongoing educational interventions are warranted to improve knowledge and perceptions of HCWs. Recent Publications: 1. Mohammadjavad Ashrafi Mahabadi.Healthcare Workers' Knowledge and Perception of the SARS-CoV-2 Omicron Variant: A Multinational Cross-Sectional Study. Healthcare (Basel). 2022 Feb25;10(3):438. doi: 10.3390/healthcare10030438. 2. Mohammadjavad Ashrafi Mahabadi Knowledge and Perceptions of COVID-19 Among Health Care Workers: Cross-Sectional Study. JMIR Public Health Surveill 2020;6(2):e19160 doi:10.2196/19160

Biography Mohammadjavad Ashrafi Mahabadi, an M.D. from the Iran university of medical sciences. His primary research interests are investigating healthcare workers’ knowledge and perceptions about Covid-19 and its variants. He has published two papers regarding it with high citations. He is particularly interested in improving the memorization of topics, mainly through medical mnemonics. He is moderating a Telegram channel that shares his self-made mnemonics there for free from 2018. 

Journal of Immune Disorders & Therapy

[email protected]

COVID Mutations 2022

Volume 05

June 09, 2022 | Webinar Page 9

Indrajeet Kumar, J Immune Disord Ther,

Annual Congress on

Volume 05

COVID & COVID Mutations June 09, 2022 | Webinar

Indrajeet Kumar Hindu University, India Received date: 07-03-2022 | Accepted date: 08-03-2022 | Published date: 30-06-2022

Role of plant and algal metabolites in the fight against COVID-19 pandemic

A

sudden outbreak of viral infections has played havoc on human health, posing a serious health risk and causing significant economic harm. For the past two and a half years, the globe has been dealing with the challenges of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, which was initially detected in Wuhan at the end of 2019 and has since spread globally. As a result, the World Health Organization has declared the virus's disease a global pandemic. To combat COVID-19, researchers are constantly developing and implementing rapid diagnostics, safe and effective immunizationsand other nontraditional therapeutic approaches. Natural product-based cures and medicines, on the other hand, have aroused scientists' interest due to synthetic drug-related adverse effects and excessive prices. Antiviral compounds generated from natural resources, as well as some pharmaceuticals, have become increasingly popular in this regard. Plants/plant parts/natural products (extracts and/or metabolites) have been used to treat many human ailments in allopathic andAyurvedic medicine since ancient times. Plant metabolites are currently used in more than 25% of modern medicine and by approximately 80% of the world's population for basic health care. Several plants have been shown to have antiviral and immunomodulatory properties. Immunomodulatory effects have been documented in a variety of plants. They work by boosting cytokines selectively, activating lymphocytes, increasing natural killer cell countsand improving macrophage functions. Essential oils derived from herbs have been shown to boost the innate cellmediated immune response, making them useful as an immunological regulator against infectious illnesses. Algae, in addition to plants, are a rich source of antiviral and immunity-boosting chemicals such as lectins and sulfated polysaccharides. Furthermore, antibodies and vaccine raw materials against COVID-19 can be made from algae-derived chemicals or metabolites. Furthermore, several algae species have been shown to increase immunity and lower viral activity in humans, making them suitable for use as a COVID-19 prophylactic treatment. Using these immunomodulatory herbs and algae in combination could boost the immune system and protect the body from COVID-19. These findings, however, must be confirmed through scientific or clinical research. Recent Publications: Indrajeet Kumar. Risk assessment of heavy metal contaminated vegetables and cereal crops from carpet industrial effluents irrigated areas of northern India. Antioxidants 11. February 2022. 0.3390/antiox11030452 Indrajeet Kumar. Isolation, Identification and Characterization of Cadmium Resistant Rhizobacterial Isolates from LongTerm Wastewater Irrigated Soils. February 2022. Journal of Scientific Research. 10.37398/JSR.2022.660122 Indrajeet Kumar. Effects of Bacterial Consortium on Heavy Metal Accumulation and Growth Performance of Zea mays L. Plants. September 2021. 110 Biography

Indrajeet Kumar is currently working as assistant professor at department of botany, B.R.D. Govt. P.G. College, Duddhi, Sonbhadra, U.P. India. He has completed his graduation in botany (honours), Master of science in botany and pursuing doctor of philosophy (Ph.D.) degree from centre of advanced study in botany, institute of science, banaras hindu university, Varanasi, India. He is working in the field of plant based natural products for human welfare and heavy metal contamination in food and in herbal raw materials. He has total 9 publications in national and international journals.  Journal of Immune Disorders & Therapy

[email protected]

COVID Mutations 2022

Volume 05

June 09, 2022 | Webinar Page 10

COVID Mutations 2022 Page 11

Upcoming Conferences 2nd Annual Congress on

COVID & COVID Mutations September 05-06, 2022 | Webinar

COVID Mutations 2022 Page 12

Annual Congress on COVID & COVID Mutations June 09, 2022 | Webinar

Scientific Tracks & Abstracts

Page 13

June 09, 2022

Sessions COVID | Virus in Body | Post COVID consequences | Symptomology of COVID Session Introduction

Title: Evaluating knowledge level of rational drug use in patients with COVID-19 Sengal Bagci | Taylan Hakkari University | Turkey Title: Targeting the conserved sequence of the substrate for the proteinase of SARS-CoV-19 using nano-networks: Efficacy, stabilityand no cytotoxicity Alaa F Nahhas | King Abdulaziz University | KSA Title: About COVID- 19 in Africa: Understanding the environment pollution by the pandemic in Chad during the mutations Appolinaire Rititingar | Campus Numrique Francophone | Chad Title: The challenges Of Covid-19 and the Novel vaccines Jane Lucie Kimani | Madre Giuseppina Vannini Hospital | Italy

COVID Mutations 2022 Page 14

Annual Congress on

Sengal Bagci Taylan, J Immune Disord Ther, Volume 05

COVID & COVID Mutations June 09, 2022 | Webinar Received date: 19-02-2022 | Accepted date: 20-02-2022 | Published date: 30-06-2022

Evaluating knowledge level of rational drug use in patients with COVID-19 Sengal Bagci Taylan Hakkari University, Turkey

T

he COVID-19 pandemic has changed many things in people's lives. It has led to an increase in awareness, especially on health. Knowledge of rational drug use (RDU), which is of great importance in the fight against COVID-19, has an important place in health awareness. According to the World Health Organization, rational drug use is the patients' use of drugs that are suitable for their clinical needs, at the lowest costand to use them for a sufficient period of time, in doses as much as their individual needs. Irrational or non-rational use is the use of drugs that result in serious morbidity and mortality and lead to reduced access and attendance rates due to medicine stock-outs and loss of patient confidence in the health system. Therefore, evaluating the level of knowledge of patients in rational drug use will enable us to identify deficiencies and gain important ideas about the correct management of the COVID-19 pandemic. In our study, we aimed to determine the knowledge level of RDU in patients who tested positive for COVID 19 at least two weeks ago. We carried out our work between March 2021 and December 2021. We used random sampling method. We applied the Rational Drug Use Scale (RDUS), of which Demirtaş et al. (2018)* validated its validity and reliability, to volunteer patients aged 18-85 years who had positive COVID-19 test at least two weeks ago. We collected our data using patient demographic form and RDUS. Demographic data were expressed as a percentage value. RDUS data were expressed as score. Responses for each question were calculated as I don’t know=0, no=1, yes=2 scores. In the scale containing 21 questions, the minimum score was 0 and the maximum score was 42. SPSS 22.0 was used for statistical analysis of data. Student t test and ANOVA test were used for the statistical analysis of our normally distributed data. The difference was considered as statistically significant with P